Gyon Technologies Capital Management, LP United Therapeutics Corp Transaction History

Gyon Technologies Capital Management, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$205.95 - $280.43 $1.65 Million - $2.24 Million	-7,994 Reduced 59.55%	5,431 $1.51 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $1.61 Million - $1.93 Million	7,908 Added 143.34%	13,425 $2.81 Million
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $432,130 - $596,098	2,472 Added 81.18%	5,517 $1.3 Million
Q1 2022 May 12, 2022	SELL	$166.16 - $213.96 $364,887 - $469,856	-2,196 Reduced 41.9%	3,045 $546,000
Q4 2021 Feb 11, 2022	SELL	$184.32 - $216.08 $2.06 Million - $2.42 Million	-11,181 Reduced 68.09%	5,241 $1.13 Million
Q3 2021 Nov 18, 2021	BUY	$179.86 - $214.88 $825,197 - $985,869	4,588 Added 38.77%	16,422 $3.03 Million
Q2 2021 Aug 16, 2021	BUY	$170.47 - $211.93 $1.09 Million - $1.35 Million	6,383 Added 117.1%	11,834 $2.12 Million
Q1 2021 May 17, 2021	SELL	$153.94 - $174.85 $3.92 Million - $4.46 Million	-25,482 Reduced 82.38%	5,451 $912,000
Q4 2020 Feb 16, 2021	BUY	$101.87 - $151.79 $2.38 Million - $3.55 Million	23,397 Added 310.47%	30,933 $4.7 Million
Q3 2020 Nov 16, 2020	BUY	$99.9 - $121.13 $752,846 - $912,835	7,536 New	7,536 $761,000
Q1 2020 May 15, 2020	SELL	$79.39 - $115.35 $888,056 - $1.29 Million	-11,186 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$78.31 - $95.34 $875,975 - $1.07 Million	11,186 New	11,186 $985,000

669

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.